OliX Pharmaceuticals,Inc (226950.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 2.83T |
| Enterprise Value | 2.85T |
| P/E Ratio | -205.51 |
| PEG Ratio | -1.51 |
| Price/Sales Ratio | 145.59 |
| Price/Book Ratio | 19.01 |
| Enterprise/Revenue | 146.21 |
| Enterprise/EBITDA | -133.21 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.71 |
| Operating Margin | -1.88 |
| Return On Assets | -0.07 |
| Return On Equity | -0.11 |
| Revenue | 14.67B |
| Revenue/Share | 777.2 |
| Gross Profit | 14.67B |
| EBITDA | -27.52B |
| Net Income | -16.23B |
| Diluted EPS | -804 |
| Total Cash | 127.88B |
| Total Cash/Share | 5,757.29 |
| Total Debt | 21.79B |
| Total Debt/Equity | 0.15 |
| Current Ratio | 6.59 |
| Book Value Per Share | 6,545.83 |
| 52-Week Change | 217.84 |
| 52-Week High | 217,000 |
| 52-Week Low | 34,500 |
| Moving Average 50 Days | 158,540 |
| Moving Average 200 Days | 138,824.5 |
| Average Volume | 319,336 |
| Shares Outstanding | 20.3M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | December 03, 2020 |